May 6 (Reuters) - Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration has ...
Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health ...
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies ...
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to as fast as two months, according to an Oct. 16 ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...
The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE: MRK) drugs with potential blockbuster sales. Merck's cholesterol treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results